A carregar...
Developing a Canadian Real-World Evidence Action Plan across the Drug Life Cycle
Policy makers face challenges with the number of drugs for rare indications and rapidly rising costs. In facing these challenges, decision-makers see real-world evidence (RWE) as an opportunity. Health Canada and the Canadian Agency for Drugs and Technologies in Health (CADTH) recently announced the...
Na minha lista:
| Publicado no: | Healthc Policy |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Longwoods Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294449/ https://ncbi.nlm.nih.gov/pubmed/32538348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12927/hcpol.2020.26225 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|